신현재 (서울대학교 의과대학)님 | 한빛사연구자 > 한빛사

서울대학교 의과대학

최종업데이트 2025.11.27.

Aspirin and HCC risk in MASLD: Nationwide cohort study with genetic risk analysis
- Clin. Mol. Hepatol., Nov 25 2025, | https://doi.org/10.3350/cmh.2025.0528
- 2025-11
- 한빛사논문
AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B
- J. Hepatol., Dec 20 2024, S0168-8278(24)02784-3 | https://doi.org/10.1016/j.jhep.2024.12.029
- 2024-12
- 의약학
- 한빛사논문
[Correspondence] Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial
- Lancet, Aug 17 2024, 404 (10453) S0140-6736(24)00797-9 | https://doi.org/10.1016/S0140-6736(24)00797-9
- 2024-08
- 의약학
- 한빛사논문
Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B
- J. Med. Virol., 28 June 2024 | https://doi.org/10.1002/jmv.29760
- 2024-06
- 의약학
- 한빛사논문
Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: A mendelian randomization and population-based cohort study
- Hepatology, Mar 11 2024, | https://doi.org/10.1097/HEP.0000000000000837
- 2024-03
- 의약학
- 한빛사논문

연구자 ID

저자논문